Table 5. Comparing costs of HIV treatment and care across similar studies in sub-Saharan Africa.
| Study (year of costing) | Country | HIV Prevalence % [44] (year) | Cost/person year US$ | Cost/person year 2012 US$ [45] |
| Our Study (2012) | Burkina Faso | 1.2 (2009) | 1098 | 1098/ |
| Harling et al, 2007 [46] (2004) | South Africa | 17.8 (2009) | 432** | 524 |
| Houton et al, 2008 [43] (2006) | Benin | 1.2 (2009) | 1160 | 1318 |
| Rosen et al, 2008 [39] (2006) | South Africa | 17.8 (2009) | 928 (756–1156) | 1055(859–1314) |
| Menzies et al, 2011 [47] (2009) | Ethiopia Nigeria Uganda | 2.1 (2007) 3.6 (2009) 6.5 (2009) | 682 988 843 | 728 1055 900 |
| Jaffar et al, 2009 [48] (2008) | Uganda | 6.5 (2009) | 834 | 887 |
| Bikilla et al, 2009 [49] (2006) | Ethiopia | 2.1 (2007) | 269 | 326 |
| Degahye et al, 2006 [50] (2004) | South Africa | 17.8 (2009) | 739–1073* | 962–1301 |
| Martinson et al 2009 [51] (2004) | South Africa | 17.8 (2009) | 1177 | 1428 |
| Tagar et al 2012 [52] | Malawi Ethiopia Rwanda Zambia South Africa | 10.8 (2012) 2.1 (2007) 2.9 (2012) 12.7 (2012) 17.8 (2009) | 136 186 232 278 682 |
*converted from Rand **result given per month.